Movatterモバイル変換


[0]ホーム

URL:


US3888253A - Device for administration of medicines - Google Patents

Device for administration of medicines
Download PDF

Info

Publication number
US3888253A
US3888253AUS477487AUS47748774AUS3888253AUS 3888253 AUS3888253 AUS 3888253AUS 477487 AUS477487 AUS 477487AUS 47748774 AUS47748774 AUS 47748774AUS 3888253 AUS3888253 AUS 3888253A
Authority
US
United States
Prior art keywords
housing
capsule
capsule holder
piercing
flow
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US477487A
Inventor
Peter Ridgway Watt
Harold George Wilkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB3642872Aexternal-prioritypatent/GB1404338A/en
Application filed by Beecham Group PLCfiledCriticalBeecham Group PLC
Priority to US477487ApriorityCriticalpatent/US3888253A/en
Application grantedgrantedCritical
Publication of US3888253ApublicationCriticalpatent/US3888253A/en
Anticipated expirationlegal-statusCritical
Expired - Lifetimelegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

A device for the oral inhalation of finely divided solid medicaments, which comprises within a housing a capsule holder fixed to an elongate vibratable member which is fixed to the housing. A capsule in the capsule holder is pierced and inhalation by a patient causes the vibratable member to vibrate, medicament is shaken from the capsule and inhaled into the patient''s lungs.

Description

United States Patent [191 Watt et al.
[ DEVICE FOR ADMINISTRATION OF MEDICINES [75] Inventors: Peter Ridgway Watt, Ewhurst;
Harold George Wilkinson, Goring-by-Sea, both of England [73] Assignee: Beeeham Group Limited, England [22] Filed: June 7, 1974 [2!] Appl. No.; 477,487
Related U.S. Application Data [63] Continuation of Ser. No. 382,214, July 24, 1973,
abandoned.
[30] Foreign Application Priority Data Aug. 4, 1972 United Kingdom 36428/72 [52] U.S. Cl 128/266; 128/208 [51] Int. Cl. A6lm 15/00; Afilm 15/06 [58] Field of Search [28/198, 206, 208, 266
[56] References Cited UNITED STATES PATENTS 2,946,332 7/l960 Sacks 128/266 June 10, 1975 3,507,277 4/1970 Altounyan 128/208 3,669,1l3 6/l972 Altounyan i t l28/266 333L606 8/[974 Damani I28/266 FOREIGN PATENTS OR APPLICATIONS 1,338,254 11/1973 United Kingdom 1,! 18.34I 7/l968 United Kingdom Primary Examiner-Aldrich F. Medbery [57] ABSTRACT 24 Claims, 13Drawing Figures PATENTEDJUH 10 I975 SHEET MOP SHEET PATENTEDJUH I 0 I975 wmh hwh mm POM vow wmm w wow PNN Pow
NON
S E aw DEVICE FOR ADMINISTRATION OF MEDICINES This is a continuation, of application Ser. No. 382.2l4 filed July 24, 1973. and now abandoned.
This invention relates to a device for the application of finely divided solid medicamcnts by oral inhalation.
The application of medicaments by oral inhalation, inhalation therapy, is of considerable value in treating ailments of the bronchial tract and of the lungs. and the route is also of value in the systemic application of medicaments.
In order to obtain the maximum beneficial effect the medicament should be carried to the area to be treated in the form of fine particles suspended in the inhaled air. In the past this has been achieved for example, by applying the medicament with a ncbuliser or by applying the medicament from a solution or suspension in a pressurised pack. Both of these methods are however, rather costly, and in the case of the pressurised pack, the apparatus is not reusable. A disadvantage of the nebuliser is the difficulty of administering an exact predetermined dose of medicament. Devices are known for the insufflation of powdered medicament but many require an additional source of power besides the patients inhalation to blow the powder out of the device. Examples of such additional sources of power include for example a rubber squeeze bulb (see Belgian Pat. No. 764,576) or a source of gas under pressure (sec British Pat. No. 1,305.l72). In such devices it is diffcult to synchronise the patients inhalation with the operation of the additional source of power. Other inhalation devices which are activated solely by the users inhalation are described in British Pat. Nos. l,l l8,34l, l,l82,779, l,l22,284, l,295,08l. l,30l,856 US. Pat. No. 3.635.2l9, and Belgian Pat. No. 781,]02.
According to the present invention, there is provided a device for the oral inhalation of finely divided solid medicaments which device comprises a hollow housing and a capsule holder fixed to an elongate vibratable member which is fixed towards one end within the housing at a point remote from the capsule holder, said housing having inlet and outlet vents permitting air to flow through the housing the outlet vent being adapted for application to or insertion into the mouth and the interior of the housing being constructed and arranged so that the intake of breath by the user of the device through the outlet vent causes a turbulent airstream to flow within the housing which in turn causes the said member to vibrate. In use the device of this invention is first loaded by placing a capsule containing finely divided medicament into the capsule holder. As the patient inhalcs through the outlet vent the vibratable member vibrates in the turbulent airstream which is set up within the hollow housing and the capsule holder and the capsule held therein vibrate along with the vibratable member. Providing the capsule is pierced. the finely divided medicament is shaken from the capsule by the vibration into the interior of the housing. It is then caught up in the airstream and is carried through the outlet vent and down into the users lungs. It will thus be clear that the medicament capsule must either be pierced before insertion into the capsule holder or must be pierced in situ. This latter method is most convenient and thus in a preferred embodiment of this invcntion the device is provided with means for piercing a medicament capsule in situ in the device.
The capsule may be pierced at any position on its surface and the preferred position of piercing depends on the particular embodiment of the invention, as will be discussed below.
For ease of access to the interior of the housing in order to load the device with a medicament capsule. part of the housing may be detachable cg. by way of screw threads or a snap-on/snap-off locking mechanism. The hollow housing may conveniently be long and narrow with the vibratable member mounted longitudinally within the housing. With this embodiment a pleasing slim shape may be achieved.
The elongate vibratable member may be in the form of a long narrow flat strip of a suitable material e.g. a metal or plastic reed, such that the primary component of vibration is in a single plane i.e., the vibration corre' sponds roughly to harmonic motion. Alternatively. the vibratable member may be in the form of a rod or spindle which is able to vibrate in any direction at right angles to its long axis. Preferably the rod is circular in cross-section.
A capsule holder is fixed to one end ofthc vibratable member. Preferably the capsule holder is located near the air outlet in the housing. The capsule holder may be in the form of a simple cup into which the capsule fits securely. It is then advantageous to position the capsule holder in a constricted neck region within the hollow housing e.g. an approximate Venturi orifice in order to give a minimum pressure area in the vicinity of the capsule when the patient inhales through the air outlet vent. Alternatively the capsule holder may be in the form of a cup which has a passage to allow a flow of air from within the hollow housing to one end of the major axis of the capsule.
The device of this invention also has at least one outlet vent and one or more inlet vents. Preferably the device has only one outlet vent, and one or more inlet vents. In the case where there is one inlet vent. this may be in the end or in the sides of the device. Further inlet vents may be provided in the end or the sides of the device for example there may be one main inlet in the end and one or more subsidiary inlets e.g. the sides of the device.
When the vibratable member is in the form of a reed, it is preferably that the cross-sectional area of the outlet vent is of the same general magnitude as the total cross-sectional area of the inlet vents.
The interior of the housing of the device is constructed and arranged so that the intake of breath by the user of the device through the outlet vent causes a turbulent airstream to flow within the housing which in turn causes the said member to vibrate. Such construe tion depends on the method desired to achieve dispersion of the medicament in the air stream. When the vibratable member is in the form of a reed turbulent airflow within the housing may be ensured by the provision of baffles within the housing and/or on the vibratable member itself. A second possible method of producing the required turbulence. preferred when the vibratable member is in the form or a rod, is to provide a number of inlet vents in the side of the device in the region of the capsule holder. Preferably these inlets are angled or are positioned adjacent internal angled barriers. so that incoming air is directed to a circular path.
Dispersion of the medicament from the capsule may be further facilitated and turbulence increased by providing the capsule holder with a protuberance. for example in the form of a disc which is able to strike the inner walls of the housing when the vibratable member vibrates.
Suitably the device also incorporates a means for piercing the medicament capsule. In the embodiments wherein the capsule holder is in the form of a simple cup preferably the capsule is pierced on opposite sides of its major axis. When the capsule holder is in the form having an air passage it is preferable to pierce the capsule along its major axis so that the two ends each have one centrally placed hole through them.
It is usually preferable to position a guard grid in the outlet vent in order to prevent the entire capsule from being inhaled by the patient should some mishap dislodge the capsule from the capsule holder. In the case of patients who find it difficult to inhale strongly the airflow through the housing may be supplemented by an additional source of power such as a rubber squeeze bulb which is squeezed as the the patient inhales. With such an embodiment the bulb must be fitted to an air inlet in the housing leaving another air outlet free to allow the user of the device to inhale.
The invention will now be illustrated in some of its specific embodiments with reference to the accompanying drawings wherein:
FIG. 1 is a cross section of an oral inhalation device in accordance with this invention;
FIG. 2 is a cross section of a second device in accordance with this invention;
FIG. 3 is a cross section through the line AA of HQ. 2;
FIG. 4 is a cross section of a third device in accordance with this invention;
FIG. 5 is a cross section of a fourth device in accordance with this invention;
FIG. 6 is a cross section of a further device in accordance with this invention;
FIG. 7 is a cross section through the line 8-5 of FIG. 6',
FIG. 8 is a cross section through the line CC of FIG. 6;
FIG. 9 is a cross-section ofa further device in accor dance with this invention;
FIG. 10 is a cross-section through line DD of HO. 9;
FIG. 11 is a cross-section through line E-E of FIG.
FIGS. 12 and 13 are cross-sections of two further, preferred devices in accordance with this invention.
Referring first to FIG. 1 ahollow housing 1 contains capsule holder 2 which is shown as holding acapsule 3 containing finely divided medicament. The capsule holder 2 is mounted on the end of a vibratable member in the form ofareed 4 which is fixed at the end remote from the capsule holder to aprojection 5 extending from the housing. Air inlet vents 6 and air outlet vents 7 permit the passage of air through the housing. The outlet vents 7 are adapted to be inserted into the mouth by suitably shaping the housing in the vicinity of the outlet vents.Baffles 8 project from the wall of the housing in a direction normal to the logitudinal axis of the housing and a cooperating baffle 9 is mounted on the vibratable member. The dimensions and location of cooperating baffle 9 are chosen to leave a small gap 11 betweenbaffles 8 and co-operating baffle 9.Constrictions 10 form a neck region about the capsule and capsule holder.
In use the patient inserts the portion of the housing in the vicinity of outlet vent 7 into his mouth having first loaded the device with acapsule 3. The capsule may either be pierced before loading or pierced in situ by a mechanism not shown in FIG. 1. In order to load the device the housing is separable at points X by screw threads (not shown). The patient then inhales through outlet vents 7 thereby drawing air through the inlet vents 6 and thence through thehousing 1. As the airstream negotiatesbaffles 8 and 9 via the gap 11, an aerodynamically unstable situation arises at the gap 11. The vibratable member begins to vibrate in the plane of the drawing and the medicament is shaken from the pierced capsule into the interior of the housing. It is then caught up in the airstream and drawn down into the patients lungs as he inhales. The constricted neck formed by theconstrictions 10 ensures a minimum pressure area in the vicinity of the capsule thereby assisting in the dispersal of the medicament.
FIGS. 2 and 3 represent a device similar to that of FIG. 1. Again ahollow housing 101 contains acapsule holder 102 fitted with acapsule 103 of finely divided medicament. A harmonically vibratable member in the form of areed 104 is fixed toprojection 105 from the housing at the end remote from thecapsule holder 102. The housing again may be separated at point Y and the capsule may either be pierced before loading or pierced in situ. The housing has inlet vents 106 and outlet vents 107. The vibratable member carriesbaffles 109 positioned adjacent the inlet vents 106, with a small gap betweenbaffles 109 and thewall 108 of the inlet vents 106.
In operation as the patient inhales through inlet vents 107 air flows into the device throughinlet vent 106. As the airstream negotiates the gap betweenbaffle 109 andwalls 108, again an unstable aerodynamic situation is set up and the vibratable member vibrates in the plane of the drawing.
FIG. 4 represents another device in accordance with this invention. Again ahousing 201 contains acapsule holder 202 fitted with acapsule 203, the capsule holder mounted on a vibratable member in the form of areed 204 fixed toprojection 205. The housing has inlet vents 206 in its side and outlet vents 207. Thewalls 208 of the inlet vents define slots 213. The vibratable member has mounted thereonbaffles 209 which have leading edges 212 positioned near to and parallel to longitudinal slots 213.
As air is sucked through inlet vents 206 and thence through slots 213, the airstream plays on leading edges 212 ofbaffles 209 and causes the entire vibratable member to vibrate.
FIG. 5 represents another device in accordance with this invention. Again ahousing 301 contains acapsule holder 302 fitted with acapsule 303, the capsule mounted on a vibratable member in the form of areed 304 fixed within the end of thehousing 305. The housing has oneinlet vent 306 in its side and outlet vents 307. Thereed 304 is able to move away frominlet vent 306 and expose anannular gap 314. The region of the housing near to theoutlet 307 is provided with aplug 315 which is drilled with ahole 316. The crosssectional area of thehole 316 is approximately equal to the area of theannular gap 314 exposed at the maximum excursion position. For example using a device with a reed about 12 mm wide covering acircular inlet vent 306 ofdiameter 8 mm it is possible to produce an ampitude of movement of some 0.5 mm at the midpoint of theinlet vent 306. The area of the annular gap exposed at the maximum excursion position is thus fractionally over 12 mm. An area of 12 mm corresponds also to a circular hole of about 4 mm diameter. Thus ahole 316, ofdiameter 4 mm is provided in theplug 315.
In operation a pulse of air passes through theiniet vent 306 lifting thereed 304 slightly and travels on towards theoutlet vent 307. As the air reaches theplug 315 its movement is restricted and consequently the rate of air intake is reduced and thereed 304 closes. The contained air passes through the outlet vents 307 so that the internal pressure is reduced. and the reed is once again opened by the external air pressure. A continuation of this sequence causes the reed to move up and down, and the rate at which this happens will tend to set at a natural resonant frequency of the reed.
FIGS. 6 to 8 represent a further device in accordance with this invention. Ahollow housing 401 contains acapsule holder 402 fitted with acapsule 403 of finely divided medicament. A vibratable member in the form of arod 404 is fixed to the end of the housing. The housing again may be separated at a point 2. The housing has inlet vents 406 and anoutlet vent 407. The inlet vents 406 are in the form of holes drilled roughly tangentially in the housing in the region of thecapsuleholder 402, as shown in FIG. 7. The housing has onefurther inlet vent 406a near the end of the housing to which therod 404 is attached. Thecapsule holder 402 has aninternal passage 417 and acircular disc 418, which is of larger diameter than thecapsule holder 402. A sharpened piercingmember 421 is slidably mounted coaxially within the housing by means of aspider arrangement 420.
The extension of theoutlet vent 407 projects slightly into the main housing thereby forming anannular trough 422.
In operation the device is first separated at points Z loaded with acapsule 403 and the two halves of the housing are reassembled. The capsule is then pierced at both ends of its major axis by moving the piercingelement 421 through the capsule and out again. The patient then inhales through theoutlet vent 407 thereby drawing air through thetangential holes 406, inducing a vortex in the region of thecapsule holder 403. Providing the flow rate is sufficient thecapsule holder 403 is thereby made to rotate in an orbital movement such that thedisc 418 strikes the inside of the housing in a succession of light blows. The orbital movement coupled with the tapping effect fluidises the powder inside the capsule so that aggregates are dispersed. At the same time air is drawn in through theinlet vent 406a, passes through the device towards theoutlet vent end 407. As the airstream reaches thecapsule holder 402, some passes into thepassage 417 and thence through thepierced capsule 403. The rapid vibration of thecapsule 403 ensures that the powdered medicament issues freely from the hole at the end nearest theoutlet vent 407. The remaining portion of the airstream fromvent 406a reaches thedisc 418 and causes further turbulcnce in the vicinity of the capsule. As the powder issues from the capsule it is caught up in the airstream and is carried towards theoutlet vent 407. As the stream of circulating particles passes through the housing. centrifugal force holds particles above a given size against the walls of the housing and they circulate within thetrough 422, while entrainment in the air flow carries finer particles down theoutlet vent 407 and into the patients lungs.
During their rotation in thetrough 422, the large particles are subject to attrition by rubbing themselves against the walls of the housing so that progressively more material is released at a low particle size and escape through theoutlet vent 407.
An important benefit to be derived from this particular design is case of construction and assembly. The moving part does not have to be in a critical relation with the static part and as a result of this it is possible to form the assembly from injection mouldings pro duced in low-cost moulds. Small variations in the shape and size of the moulded parts do not matter particularly and the device works without the necessity for close alignment.
An important characteristic of the preferred device as described with reference to FIGS. 6 to 8 is that vibration does not take place below a certain critical level of air flow; consequently active release of the powdered medicament is always associated with a certain minimum amount of lung ventilation and this ensures effective transfer of the powder to the lungs. In general this critical level will be at or about 30-35 l/min of air flow. but the rate is pre-determined by the number and disposition of the holes through which air passes into the device on suction.
It is possible by covering one such hole with the finger to ensure that powder is released on a reduced rate of air-flow rather than or the normal one. This feature could be of use, for example in the administration of medicaments by adults to small children with relatively low lung capacity.
FIGS. 9 11 represent a preferred embodiment of the device of this invention. Ahollow housing 501 contains acapsule holder 502 to carry a capsule (not shown) of finely divided medicament. A vibratable member in the form of aplastic rod 504 is fixed at one end to thecapsule holder 502 and at the other end to apush button 505 slidably mounted within one end of thehousing 501.
Areturn spring 524 is situated between thepush button 505 and anannular stop 525.
The housing is separable into two parts by means of ascrew thread 523. The housing has inlet vents 506 and anoutlet vent 507. The inlet vents 506 are in the form of holes drilled roughly tangentially in the housing in the region of the capsule-holder 502 as shown in FIG. 10. Thecapsule holder 502 carries a hollow piercingmember 517 having a tapered end which is extended through to the back of the capsule holder. Thecapsule holder 502 also carries acircular disc 518 which is of larger diameter than the capsule-holder 502. A second sharpened piercing member is fixed coaxially within the housing near to theoutlet vent 507 by means of aspider arrangement 520. The region of the housing near to theoutlet 507 is provided with aplug 515 which is drilled with ahole 516.
In operation, the device is first separated into two parts by unscrewing at thescrew thread 523, and the capsule-holder 502 loaded with a capsule by impaling the latter onto the hollow piercingmember 517, thereby piercing one end of the capsule. The two halves of the housing are then reassembled. Thepush button 505 is then depressed by hand against thespring 524, thus moving the capsule onto the second piercingmember 521 and piercing its other end. Thespring 524 then causes the return of the capsule holder to its original position. The patient inhales through theoutlet vent 507 thereby drawing air through thetangential holes 506, inducing a vortex in the region of thecapsule holder 502. Thecapsule holder 502 is thus made to rotate in an orbital movement such that thedisc 518 strikes the inside of the housing in a succession of light blows. The orbital motion coupled with the tapping effect again fluidises the powder within the capsule. At the same time some of the air drawn in through the inlet vents 406 passes behind thedisc 518 intoextended passage 517 and thence through the pierced capsule. As the powder issues from the capsule it is caught up in the vortex of air and carried towards theoutlet vent 507. As with the embodiment of FIG. 6, the finer particles in the air stream pass through thehole 516 theoutlet vent 507 and into the patients lungs. Coarser particles are held back by theannular plug 515 until they are reduced in size by attrition sufficiently to escape through thecentral hole 516.
FIGS. 12 and 13 represent embodiments of the device substantially similar to that shown in FIG. 9, but with modifications of the method of piercing the capsule.
In FIG. 12 the end of the vibratable member in the form of arod 604 is attached to aknob 605. integral with anouter sleeve 626 which fits over the outside of the housing 60!. Again aspring 624 returns the knob and sleeve to its original position after if has been depressed during the piercing operation. Alternatively the end of thehousing 627 which carries theknob 605 may be provided with a coarse screw thread to co-operate with a similar thread (not shown) on theouter surface 628 of the knob. in such an embodiment. when thesleeve 626 is depressed it also rotates and the capsule in thecapsule holder 602 is rotates onto the fixed piercingmember 621. This rotating action during the piercing produces an easier and more reliable piercing.
A similar arrangement is shown in FIG. 13. Again the fixed end oftherod 704 is attached to aknob 705 integral with asleeve 726 which fits over the outside of thehousing 701. The outer surface of theknob 705 is provided with ascrew thread 728 which screws into asimilar thread 727 on the end of the housing. Acoiled spring 724 is situated in the annular space between theknob 705 and thesleeve 726, one end being attached to the housing and the other end to the sleeve. To pierce the capsule. the sleeve is screwed in. thereby rotating the capsule contained in theholder 702 onto the fixed piercingmember 721 and also imparting torsional tension to thespring 724. When the sleeve is released. the coiled spring exerts torsional torque to the sleeve to unscrew and return the sleeve to its original position. thereby withdrawing the capsule from the piercingmember 721.
We claim:
I. A device for the oral administration of finely di' vided solid medicaments which device comprises a hollow housing, an elongate semi-flexible vibratable memher which is fixed adjacent one end thereof within the housing and free at the other end. a capsule holder at tachcd to said end of the vibratable member at a point remote from its fixed end; said housing having inlet and outlet vents permitting air to flow through the housing. the outlet vent being adapted for application to or insertion into the mouth; and means for causing said member to vibrate comprising directed air flow means reacting with said flexible vibrating member.
2. A device according toclaim 1 wherein the air flow means for causing said member to vibrate is provided by the construction and arrangement of said inlet vents such that a turbulent airstream is caused to flow through the housing between the vents by the intake of breath by the user which flow in turn causes said member to vibrate.
3. A device according toclaim 1 wherein the air flow means for causing said member to vibrate is provided by the construction and arrangement of air flow control means on the interior of the housing such that a turbulent airstream is caused to flow through the housing be tween the vents by the intake of breath by the user which flow in turn causes said member to vibrate.
4. A device according to claim I which device has only one outlet vent.
5. A device according toclaim 1 wherein the elongate vibratable member is in the form of a rod which is able to vibrate in any direction at right angles to its axis.
6. A device according toclaim 5 wherein the rod is of circular cross-section.
7. A device according toclaim 1 wherein the vibrat able member is in the form of a long narrow flat strip, such that its primary component of vibration is in a single plane.
8. A device according to claim 2 wherein the housing is provided with a plurality of inlet vents in the region of the capsule holder.
9. A device according toclaim 8 wherein said inlet vents are angled such that incoming air is directed to a circular path.
10. A device according toclaim 8 wherein said inlet vents are positioned adjacent internal angled barriers such that incoming air is directed to a circular path.
11. A device according to claim 7 wherein the crosssectional area of the outlet vent is of the same general magnitude as the total cross-sectional area of the inlet vents.
12. A device according toclaim 1 wherein the capsule holder is provided with a protuberance adapted to strike the inner walls of the housing when the vibratable member vibrates.
13. A device according toclaim 1 wherein the capsule holder is in the form of a cup adapted to securely carry a capsule.
14. A device according toclaim 1 wherein the capsule holder has a passage to allow a flow of air from within the hollow housing to one end of the major axis of the capsule.
i5. A device according toclaim 1 which device is provided with means for piercing the capsule in situ in the device.
16. A device according to claim 15 which device is provided with means for piercing the capsule at both ends of the major axis thereof.
17. A device according to claim 16 wherein the means of piercing the end of the capsule nearest to the outlet vent is in the form of a sharpened piercing member mounted within the hollow housing coaxial with the capsule holder.
18. A device according to claim 17 wherein the sharpened piercing member is slidably mounted within the housing.
19. A device according to claim 17 wherein the sharpened piercing member is fixed within the housing and the device is provided with means for moving the capsule holder towards the piercing member.
20. A device according to claim 16 wherein the means for piercing the end of the capsule furthest from the outlet vent is in the form of a sharpened hollow piercing member attached to the capsule holder onto which a capsule may be impaled.
21. A device according toclaim 1 wherein the housing is separable into two parts.
22. A device according to claim 19 wherein the two parts of the housing are adapted to be reassembled by means of a screw thread.
23. A device for the oral administration of finely divided solid medieaments which device comprises a ho]- low housing separable into two parts adapted to be reassembled by means of a screw thread; an elongate semi-flexible vibratable rod of circular cross-section which is able to vibrate in any direction at right angles to its long axis and which is fixed towards one end thereof within the housing and free at the other end; a capsule holder attached to said end of the vibratable rod at a point remote from its fixed end. the capsule holder being in the form of a cup adapted to securely carry a capsule, having a passage to allow a flow of air from within the hollow housing to one end of the major axis of the capsule and having a protuberance adapted to strike the inner walls of the housing when the vibrat able rod vibrates; said housing having one outlet vent and a plurality of inlet vents permitting air to flow through the housing, the outlet vent being adapted for application to or insertion into the mouth and the inlet vents being in the region of the capsule holder and angled such that incoming air is directed to a circular path, and in turn causes said rod to vibrate; the device being provided with means for piercing the capsule at both ends of the major axis thereof in situ in the device, the means of piercing the end of the capsule nearest the outlet vent being in the form of a sharpened piercing member fixed within the housing coaxial with the capsule holder and means for moving the capsule holder towards the piercing member, the means for piercing the end of the capsule furthest from the outlet vent being in the form of a sharpened hollow piercing member attached to the capsule holder onto which a capsule may be impaled.
24. A device for oral administration of finely divided solid medicaments which device comprises a hollow housing separable into two parts. an elongate semiflexible vibratable narrow flat strip such that its primary component of vibration is in a single plane, which is fixed towards one end thereof within the housing and free at the other end; a capsule holder attached to said end of the vibratable flat strip at a point remote from its fixed end, the capsule holder being in the form of a cup adapted to securely carry a capsule; said housing having one outlet vent and one inlet vent permitting air to flow through the housing, the outlet vent being adapted for application to or insertion into the mouth, the cross-sectional area of the outlet being of the same general magnitude as the cross-sectional area of the inlet vent. and the interior of the housing having constrictions to provide a turbulent airstream to flow through the housing between the vents by the intake of breath by the user of the device which flow in turn causes the said flat strip to vibrate.

Claims (24)

23. A device for the oral administration of finely divided solid medicaments which device comprises a hollow housing separable into two parts adapted to be reassembled by means of a screw thread; an elongate semi-flexible vibratable rod of circular cross-section which is able to vibrate in any direction at right angles to its long axis and which is fixed towards one end thereof within the housing and free at the other end; a capsule holder attached to said end of the vibratable rod at a point remote from its fixed end, the capsule holder being in the form of a cup adapted to securely carry a capsule, having a passage to allow a flow of air from within the hollow housing to one end of the major axis of the capsule and having a protuberance adapted to strike the inner walls of the housing when the vibratable rod vibrates; said housing having one outlet vent and a plurality of inlet vents permitting air to flow through the housing, the outlet vent being adapted for application to or insertion into the mouth and the inlet vents being in the region of the capsule holder and angled such that incoming air is directed to a circular path, and in turn causes said rod to vibrate; the device being provided with means for piercing the capsule at both ends of the major axis thereof in situ in the device, the means of piercing the end of the capsule nearest the outlet vent being in the form of a sharpened piercing member fixed within the housing coaxial with the capsule holder and means for moving the capsule holder towards the piercing member, the means for piercing the end of the capsule furthest from the outlet vent being in the form of a sharpened hollow piercing member attached to the capsule holder onto which a capsule may be impaled.
24. A device for oral administration of finely divided solid medicaments which device comprises a hollow housing separable into two parts, an elongate semi-flexible vibratable narrow flat strip such that its primary component of vibration is in a single plane, which is fixed towards one end thereof within the housing and free at the other end; a capsule holder attached to said end of the vibratable flat strip at a point remote from its fixed end, the capsule holder being in the form of a cup adapted to securely carry a capsule; said housing having one outlet vent and one inlet vent permitting air to flow through the housing, the outlet vent being adapted for application to or insertion into the mouth, the cross-sectional area of the outlet being of the same general magnitude as the cross-sectional area of the inlet vent, and the interior of the housing having constrictions to provide a turbulent airstream to flow through the housing between the vents by the intake of breath by the user of the device which flow in turn causes the said flat strip to vibrate.
US477487A1972-08-041974-06-07Device for administration of medicinesExpired - LifetimeUS3888253A (en)

Priority Applications (1)

Application NumberPriority DateFiling DateTitle
US477487AUS3888253A (en)1972-08-041974-06-07Device for administration of medicines

Applications Claiming Priority (3)

Application NumberPriority DateFiling DateTitle
GB3642872AGB1404338A (en)1972-08-041972-08-04Device for the inhalation of medicaments
US38221473A1973-07-241973-07-24
US477487AUS3888253A (en)1972-08-041974-06-07Device for administration of medicines

Publications (1)

Publication NumberPublication Date
US3888253Atrue US3888253A (en)1975-06-10

Family

ID=27259363

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US477487AExpired - LifetimeUS3888253A (en)1972-08-041974-06-07Device for administration of medicines

Country Status (1)

CountryLink
US (1)US3888253A (en)

Cited By (86)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3998226A (en)*1975-09-221976-12-21Edward G. GomezInhalation device for encapsulated concentrates
US4005711A (en)*1975-01-131977-02-01Syntex Puerto Rico, Inc.Inhalation device
US4811731A (en)*1985-07-301989-03-14Glaxo Group LimitedDevices for administering medicaments to patients
US4860740A (en)*1980-10-301989-08-29Riker Laboratories, Inc.Powder inhalation device
US5152284A (en)*1989-02-231992-10-06Phidea S.P.A.Disposable inhaler with pre-pierced capsule
US5161524A (en)*1991-08-021992-11-10Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5204113A (en)*1987-04-091993-04-20Fisons PlcPharmaceutical compositions containing pentamidine
WO1993025258A1 (en)*1992-06-151993-12-23Norton Healthcare Ltd.Inhaler
US5287850A (en)*1991-08-201994-02-22Habley Medical Technology CorporationTiming and velocity controlled powered pharmaceutical inhaler
US5334374A (en)*1987-04-091994-08-02Fisons PlcPharmaceutical compositions containing pentamidine
US5337740A (en)*1991-08-011994-08-16New England Pharmaceuticals, Inc.Inhalation devices
US5372128A (en)*1993-04-141994-12-13Habley Medical Technology CorporationFluidizing powder inhaler
US5388572A (en)*1993-10-261995-02-14Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en)*1993-12-021995-02-14Tenax CorporationDry powder inhalator medicament carrier
US5441060A (en)*1993-02-081995-08-15Duke UniversityDry powder delivery system
US5460173A (en)*1993-03-031995-10-24Tenax CorporationDry powder inhaler medicament carrier
WO1995031238A1 (en)*1994-05-171995-11-23Merck Patent GmbhPowder inhaler
US5524613A (en)*1993-08-251996-06-11Habley Medical Technology CorporationControlled multi-pharmaceutical inhaler
US5673686A (en)*1994-02-021997-10-07Plurichemie AnstaltMedicament inhaler and method
AU703023B2 (en)*1993-02-081999-03-11Advanced Therapeutic Products, Inc.Dry powder delivery system
US6186141B1 (en)*1996-05-102001-02-13Glaxo Wellcome Inc.Unit dose dispensing device
WO2002092154A1 (en)2001-04-262002-11-21New England Pharmaceuticals, Inc.Metered dose delivery device for liquid and powder agents
US20030131847A1 (en)*2002-01-162003-07-17Fabrizio NiccolaiDevice usable in the treatment of affections of the airways
US6732732B2 (en)2001-04-162004-05-11Advanced Inhalation Research, Inc.Inhalation device and method
WO2004054647A1 (en)*2002-12-132004-07-01Otsuka Pharmaceutical Co., Ltd.Inhalation device for transpulmonary administration
US20040206350A1 (en)*2002-12-192004-10-21Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US20050028813A1 (en)*2001-10-052005-02-10Ian HarrisonApparatus for the nasal or oral delivery of a medicament
US20050150492A1 (en)*2003-04-092005-07-14Nektar TherapeuticsAerosolization apparatus with air inlet shield
US7032593B2 (en)2000-08-142006-04-25Advanced Inhalation Research, Inc.Inhalation device and method
US20070051362A1 (en)*2004-04-232007-03-08Sullivan Timothy RMultiple unit dose drug delivery system
US20070137648A1 (en)*2005-12-162007-06-21Pneumoflex Systems, LlcIntraoral Nebulizer Providing Air Curtains
US20070209661A1 (en)*2006-03-032007-09-13Hugh SmythDry powder inhaler with aeroelastic dispersion mechanism
US20080177246A1 (en)*2007-01-092008-07-24First City TowerIntranasal Cartridge Devices
WO2008051621A3 (en)*2006-10-252008-11-13Nektar TherapeuticsPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
US20090000619A1 (en)*2004-09-232009-01-01Glaxosmithkline Pharmaceuticals S.A.Powder Inhaler, System for Opening and Emptying Capsules
US20090025721A1 (en)*2007-06-122009-01-29Alkermes, Inc.Powder inhaler devices
US20090071108A1 (en)*2007-09-142009-03-19Mystic Pharmaceuticals, Inc.Deep draw container forming method
US20090095294A1 (en)*2006-03-032009-04-16Smyth Hugh CDry powder inhaler with aeroelastic dispersion mechanism
US7669597B2 (en)2007-05-162010-03-02Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
WO2009117112A3 (en)*2008-03-212010-04-22Novartis AgPowder dispersion apparatu
US20100180894A1 (en)*2009-01-152010-07-22Andrew JonesDelivery device and related methods
JP2011212252A (en)*2010-03-312011-10-27Yoshino Kogyosho Co LtdPowder inhalation device
US20120234322A1 (en)*2009-11-122012-09-20Stc.UnmDry powder inhaler with flutter dispersion member
CN101588831B (en)*2006-10-252012-10-31诺瓦提斯公司Powder dispersion apparatus, and components that can be used on the apparatus
US20130032145A1 (en)*2008-05-012013-02-07Dan AdlerDry powder inhaler
US8561609B2 (en)2010-12-072013-10-22Respira Therapeutics, Inc.Dry powder inhaler
US8607787B2 (en)2007-07-062013-12-17Manta Devices, LlcDose delivery device for inhalation
US8671934B2 (en)2011-01-202014-03-18Pneumoflex Systems, LlcNebulizer that is activated by negative inspiratory pressure
US8683995B2 (en)2007-05-162014-04-01Mystic Pharmaceuticals, Inc.Dose dispensing containers
US8763605B2 (en)2005-07-202014-07-01Manta Devices, LlcInhalation device
US8869794B1 (en)*2003-04-092014-10-28Novartis Pharma AgAerosolization apparatus with capsule puncturing member
JP2015502172A (en)*2011-12-202015-01-22ブリティッシュ アメリカン タバコ (インヴェストメンツ) リミテッドBritish Americantobacco (Investments) Limited Smoking goods and other flow delivery items
EP2928315A2 (en)*2012-12-062015-10-14AeroDesigns, IncAerosol dispenser with edible cartridge
US9248076B2 (en)2007-05-162016-02-02Mystic Pharmaceuticals, Inc.Dose dispensing containers
CN105311717A (en)*2014-08-012016-02-10心诚镁行动医电股份有限公司Portable ultrasonic atomizer and medicine placing structure thereof
US9283336B2 (en)2010-03-192016-03-15Manta Devices, LlcDelivery device and related methods
US20160199598A1 (en)*2012-02-212016-07-14Respira Therapeutics, Inc.Powder dispersion methods and devices
US9452270B2 (en)2011-01-202016-09-27Pneumoflex Systems, LlcNebulizer having replaceable nozzle assembly and suction line
US9452274B2 (en)2011-01-202016-09-27Pneumoflex Systems, LlcMetered dose atomizer
US9550036B2 (en)2011-03-032017-01-24Impel Neuropharma Inc.Nasal drug delivery device
EP1917057A4 (en)*2005-07-202017-05-03Manta Devices, LLCInhalation device
US9649454B2 (en)2012-05-032017-05-16Manta Devices, LlcDelivery device and related methods
US9919117B2 (en)2011-05-092018-03-20Impel Neuropharma Inc.Nozzles for nasal drug delivery
US10016582B2 (en)2008-02-072018-07-10University Of Washington Through Its Center For CommercializationCircumferential aerosol device
WO2018220475A1 (en)*2017-05-312018-12-06Philip Morris Products S.A.Inhaler article with occluded airflow element
CN109688854A (en)*2016-09-142019-04-26英美烟草(投资)有限公司Receiver section
US10441733B2 (en)2012-06-252019-10-15Respira Therapeutics, Inc.Powder dispersion devices and methods
US10537692B2 (en)2013-04-282020-01-21Impel Neuropharma, Inc.Medical unit dose container
US10682476B2 (en)2012-02-212020-06-16Respira Therapeutics, Inc.Powder inhaler, system and methods
EP3519025A4 (en)*2016-09-302020-08-26De Motu Cordis Pty Ltd RELEASE DEVICE AND RELATED METHOD OF USE
WO2020178714A1 (en)*2019-03-052020-09-10Philip Morris Products S.A.Holder for inhaler article
US11103659B2 (en)2011-07-062021-08-31Manta Devices, LlcDelivery device and related methods
US11123501B2 (en)2016-03-242021-09-21Nicoventures Holdings LimitedElectronic vapor provision system
US11147936B2 (en)2014-05-022021-10-19Manta Devices, LlcDose delivery device with cover connected to dose chamber seal
US11185497B2 (en)2018-01-052021-11-30Impel Neuropharma, Inc.Intranasal delivery of dihydroergotamine by precision olfactory device
US11213638B2 (en)2016-03-242022-01-04Nicoventures Trading LimitedVapor provision system
US11224704B2 (en)2007-07-062022-01-18Manta Devices, LlcDose delivery device for inhalation
US11241043B2 (en)2016-03-242022-02-08Nicoventures Trading LimitedVapor provision apparatus
US11266799B2 (en)2015-09-102022-03-08Impel Neuropharma, Inc.In-line nasal delivery device
US11278492B2 (en)2018-01-052022-03-22Impel Neuropharma, Inc.Intranasal delivery of olanzapine by precision olfactory device
US11395887B2 (en)2017-11-212022-07-26Impel Pharmaceuticals Inc.Intranasal device with inlet interface
US20220379053A1 (en)*2019-10-252022-12-01Philip Morris Products S.A.Holder for inhaler article
US11517548B2 (en)2018-07-192022-12-06Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
US11571532B2 (en)2017-11-212023-02-07Impel Pharmaceuticals Inc.Intranasal device with dip tube
US11759585B2 (en)2019-01-032023-09-19Impel Pharmaceuticals Inc.Nasal drug delivery device with detachable nozzle
US11878109B2 (en)2019-05-172024-01-23Impel Pharmaceuticals Inc.Single-use nasal delivery device

Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2946332A (en)*1957-12-231960-07-26Nysco Lab IncInsufflator
US3507277A (en)*1966-09-171970-04-21Fisons Pharmaceuticals LtdInhalation device
US3669113A (en)*1966-03-071972-06-13Fisons LtdInhalation device
US3831606A (en)*1971-02-191974-08-27Alza CorpAuto inhaler

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US2946332A (en)*1957-12-231960-07-26Nysco Lab IncInsufflator
US3669113A (en)*1966-03-071972-06-13Fisons LtdInhalation device
US3507277A (en)*1966-09-171970-04-21Fisons Pharmaceuticals LtdInhalation device
US3831606A (en)*1971-02-191974-08-27Alza CorpAuto inhaler

Cited By (149)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4005711A (en)*1975-01-131977-02-01Syntex Puerto Rico, Inc.Inhalation device
US3998226A (en)*1975-09-221976-12-21Edward G. GomezInhalation device for encapsulated concentrates
US4860740A (en)*1980-10-301989-08-29Riker Laboratories, Inc.Powder inhalation device
US4811731A (en)*1985-07-301989-03-14Glaxo Group LimitedDevices for administering medicaments to patients
US5035237A (en)*1985-07-301991-07-30Newell Robert EDevices for administering medicaments to patients
US5334374A (en)*1987-04-091994-08-02Fisons PlcPharmaceutical compositions containing pentamidine
US5204113A (en)*1987-04-091993-04-20Fisons PlcPharmaceutical compositions containing pentamidine
US5152284A (en)*1989-02-231992-10-06Phidea S.P.A.Disposable inhaler with pre-pierced capsule
US5715810A (en)*1991-07-251998-02-10Sepracor Inc.Inhalation devices
US5529059A (en)*1991-08-011996-06-25Sepracor Inc.Inhalation devices
US5337740A (en)*1991-08-011994-08-16New England Pharmaceuticals, Inc.Inhalation devices
US5161524A (en)*1991-08-021992-11-10Glaxo Inc.Dosage inhalator with air flow velocity regulating means
US5287850A (en)*1991-08-201994-02-22Habley Medical Technology CorporationTiming and velocity controlled powered pharmaceutical inhaler
WO1993025258A1 (en)*1992-06-151993-12-23Norton Healthcare Ltd.Inhaler
AU703023B2 (en)*1993-02-081999-03-11Advanced Therapeutic Products, Inc.Dry powder delivery system
EP1470833A1 (en)*1993-02-082004-10-27Advanced Therapeutic Products, Inc.Dry powder delivery system
US5441060A (en)*1993-02-081995-08-15Duke UniversityDry powder delivery system
EP0683632A4 (en)*1993-02-082000-11-02Advanced Therapeutic Prod DISPENSING SYSTEM FOR DRY POWDER
AU693783B2 (en)*1993-02-081998-07-09Advanced Therapeutic Products, Inc.Dry powder delivery system
US5460173A (en)*1993-03-031995-10-24Tenax CorporationDry powder inhaler medicament carrier
US5372128A (en)*1993-04-141994-12-13Habley Medical Technology CorporationFluidizing powder inhaler
US5524613A (en)*1993-08-251996-06-11Habley Medical Technology CorporationControlled multi-pharmaceutical inhaler
US5388572A (en)*1993-10-261995-02-14Tenax Corporation (A Connecticut Corp.)Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same
US5388573A (en)*1993-12-021995-02-14Tenax CorporationDry powder inhalator medicament carrier
US5673686A (en)*1994-02-021997-10-07Plurichemie AnstaltMedicament inhaler and method
AU699477B2 (en)*1994-05-171998-12-03Merck Patent GmbhPowder inhaler
CN1112945C (en)*1994-05-172003-07-02默克专利股份有限公司Powder inhaler
WO1995031238A1 (en)*1994-05-171995-11-23Merck Patent GmbhPowder inhaler
US6186141B1 (en)*1996-05-102001-02-13Glaxo Wellcome Inc.Unit dose dispensing device
US7032593B2 (en)2000-08-142006-04-25Advanced Inhalation Research, Inc.Inhalation device and method
US20040216738A1 (en)*2001-04-162004-11-04Advanced Inhalation Research, Inc.Inhalation device and method
AU2002255808B2 (en)*2001-04-162007-08-02Alkermes, Inc.Inhalation device and method
US6732732B2 (en)2001-04-162004-05-11Advanced Inhalation Research, Inc.Inhalation device and method
US20040154618A1 (en)*2001-04-162004-08-12Advanced Inhalation Research, Inc.Inhalation device and method
US20040154619A1 (en)*2001-04-162004-08-12Advanced Inhalation Research, Inc.Inhalation device and method
US7278425B2 (en)2001-04-162007-10-09Alkermes, Inc.Inhalation device and method
US20060283448A1 (en)*2001-04-162006-12-21Advanced Inhalation Research, Inc.Inhalation device and method
US7146978B2 (en)2001-04-162006-12-12Advanced Inhalation Research, Inc.Inhalation device and method
EP1381416B1 (en)*2001-04-162006-01-25Advanced Inhalation Research, Inc.Inhalation device
WO2002092154A1 (en)2001-04-262002-11-21New England Pharmaceuticals, Inc.Metered dose delivery device for liquid and powder agents
US20050028813A1 (en)*2001-10-052005-02-10Ian HarrisonApparatus for the nasal or oral delivery of a medicament
US7163013B2 (en)*2001-10-052007-01-16Alchemy Healthcare LimitedApparatus for the nasal or oral delivery of a medicament
US6705313B2 (en)*2002-01-162004-03-16Ph&T S.P.A.Device usable in the treatment of affections of the airways
US20030131847A1 (en)*2002-01-162003-07-17Fabrizio NiccolaiDevice usable in the treatment of affections of the airways
WO2004054647A1 (en)*2002-12-132004-07-01Otsuka Pharmaceutical Co., Ltd.Inhalation device for transpulmonary administration
US7708014B2 (en)2002-12-132010-05-04Otsuka Pharmaceutical Co., Ltd.Inhalation device for transpulmonary administration
US20060169280A1 (en)*2002-12-132006-08-03Chikamasa YamaInhalation device for transpulmonary administration
CN100551457C (en)*2002-12-132009-10-21大塚制药株式会社 Inhalation Devices for Pulmonary Administration
EA007730B1 (en)*2002-12-132006-12-29Оцука Фармасьютикал Ко., Лтд.Inhalation device for transpulmonary administration
US20040206350A1 (en)*2002-12-192004-10-21Nektar TherapeuticsAerosolization apparatus with non-circular aerosolization chamber
US8069851B2 (en)2003-04-092011-12-06Novartis AgAeorosolization apparatus with air inlet shield
US8869794B1 (en)*2003-04-092014-10-28Novartis Pharma AgAerosolization apparatus with capsule puncturing member
USRE47526E1 (en)2003-04-092019-07-23BGP ProductsAerosolization apparatus with air inlet shield
US20050150492A1 (en)*2003-04-092005-07-14Nektar TherapeuticsAerosolization apparatus with air inlet shield
US7559325B2 (en)2003-04-092009-07-14Novartis Pharma AgAerosolization apparatus with air inlet shield
US20090260623A1 (en)*2003-04-092009-10-22Novartis Pharma AgAeorosolization apparatus with air inlet shield
US20070051362A1 (en)*2004-04-232007-03-08Sullivan Timothy RMultiple unit dose drug delivery system
US20090000619A1 (en)*2004-09-232009-01-01Glaxosmithkline Pharmaceuticals S.A.Powder Inhaler, System for Opening and Emptying Capsules
US11672927B2 (en)2005-07-202023-06-13Manta Devices, LlcInhalation device
US11491287B2 (en)2005-07-202022-11-08Manta Devices, LlcInhalation device
US10632268B2 (en)2005-07-202020-04-28Manta Devices, LlcInhalation device
US12343469B2 (en)2005-07-202025-07-01Manta Devices, LlcInhalation device
US8763605B2 (en)2005-07-202014-07-01Manta Devices, LlcInhalation device
EP1917057A4 (en)*2005-07-202017-05-03Manta Devices, LLCInhalation device
US20070137648A1 (en)*2005-12-162007-06-21Pneumoflex Systems, LlcIntraoral Nebulizer Providing Air Curtains
US20090095294A1 (en)*2006-03-032009-04-16Smyth Hugh CDry powder inhaler with aeroelastic dispersion mechanism
US20070209661A1 (en)*2006-03-032007-09-13Hugh SmythDry powder inhaler with aeroelastic dispersion mechanism
US8127763B2 (en)2006-03-032012-03-06Stc.UnmDry powder inhaler with aeroelastic dispersion mechanism
WO2008051621A3 (en)*2006-10-252008-11-13Nektar TherapeuticsPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
AU2007309412B2 (en)*2006-10-252011-10-20Novartis AgPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
US10245394B2 (en)2006-10-252019-04-02Mark GluskerPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
US20100108058A1 (en)*2006-10-252010-05-06Mark GluskerPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
RU2463085C2 (en)*2006-10-252012-10-10Новартис АгPowder spraying apparatus, method for manufacturing and using it, its components
CN101588831B (en)*2006-10-252012-10-31诺瓦提斯公司Powder dispersion apparatus, and components that can be used on the apparatus
US8573197B2 (en)2006-10-252013-11-05Novartis AgPowder dispersion apparatus, method of making and using the apparatus, and components that can be used on the apparatus and other devices
US8377009B2 (en)2007-01-092013-02-19Mystic Pharmaceuticals, Inc.Intranasal cartridge devices
US20080177246A1 (en)*2007-01-092008-07-24First City TowerIntranasal Cartridge Devices
US7669597B2 (en)2007-05-162010-03-02Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US8683995B2 (en)2007-05-162014-04-01Mystic Pharmaceuticals, Inc.Dose dispensing containers
US9248076B2 (en)2007-05-162016-02-02Mystic Pharmaceuticals, Inc.Dose dispensing containers
US9592354B2 (en)2007-05-162017-03-14Mystic Pharmaceuticals, Inc.Combination unit dose dispensing containers
US8496002B2 (en)2007-06-122013-07-30Civitas Therapeutics, Inc.Powder inhaler devices
US20090025721A1 (en)*2007-06-122009-01-29Alkermes, Inc.Powder inhaler devices
US11224704B2 (en)2007-07-062022-01-18Manta Devices, LlcDose delivery device for inhalation
US8607787B2 (en)2007-07-062013-12-17Manta Devices, LlcDose delivery device for inhalation
US9713684B2 (en)2007-07-062017-07-25Manta Devices, LlcDose delivery device for inhalation with plunger
US9919115B2 (en)2007-07-062018-03-20Manta Devices, LlcDose delivery device for inhalation with first and second portions to open a dose chamber
US20090071108A1 (en)*2007-09-142009-03-19Mystic Pharmaceuticals, Inc.Deep draw container forming method
US7963089B2 (en)2007-09-142011-06-21Mystic Pharmaceuticals, Inc.Deep draw container forming method
US10016582B2 (en)2008-02-072018-07-10University Of Washington Through Its Center For CommercializationCircumferential aerosol device
WO2009117112A3 (en)*2008-03-212010-04-22Novartis AgPowder dispersion apparatu
US20130032145A1 (en)*2008-05-012013-02-07Dan AdlerDry powder inhaler
US8550074B2 (en)2009-01-152013-10-08Manta Devices, LlcDelivery device and related methods
US20100180894A1 (en)*2009-01-152010-07-22Andrew JonesDelivery device and related methods
US9004064B2 (en)2009-01-152015-04-14Manta Devices, LlcDelivery device and related methods
US9492625B2 (en)*2009-11-122016-11-15Stc.UnmDry powder inhaler with flutter dispersion member
US20120234322A1 (en)*2009-11-122012-09-20Stc.UnmDry powder inhaler with flutter dispersion member
US9283336B2 (en)2010-03-192016-03-15Manta Devices, LlcDelivery device and related methods
JP2011212252A (en)*2010-03-312011-10-27Yoshino Kogyosho Co LtdPowder inhalation device
US8561609B2 (en)2010-12-072013-10-22Respira Therapeutics, Inc.Dry powder inhaler
US8651104B2 (en)2010-12-072014-02-18Respira Therapeutics, Inc.Bead-containing dry powder inhaler
US9452270B2 (en)2011-01-202016-09-27Pneumoflex Systems, LlcNebulizer having replaceable nozzle assembly and suction line
US9452274B2 (en)2011-01-202016-09-27Pneumoflex Systems, LlcMetered dose atomizer
US8671934B2 (en)2011-01-202014-03-18Pneumoflex Systems, LlcNebulizer that is activated by negative inspiratory pressure
US9550036B2 (en)2011-03-032017-01-24Impel Neuropharma Inc.Nasal drug delivery device
US11730903B2 (en)2011-03-032023-08-22Impel Pharmaceuticals Inc.Nasal drug delivery device
US10507295B2 (en)2011-03-032019-12-17Impel Neuropharma, Inc.Nasal drug delivery device
US9919117B2 (en)2011-05-092018-03-20Impel Neuropharma Inc.Nozzles for nasal drug delivery
US11890412B2 (en)2011-05-092024-02-06Impel Pharmaceuticals Inc.Nozzles for nasal drug delivery
US11007332B2 (en)2011-05-092021-05-18Impel Neuropharma, Inc.Nozzles for nasal drug delivery
US10940278B2 (en)2011-05-092021-03-09Impel Neuropharma, Inc.Nozzles for nasal drug delivery
US11103659B2 (en)2011-07-062021-08-31Manta Devices, LlcDelivery device and related methods
JP2015502172A (en)*2011-12-202015-01-22ブリティッシュ アメリカン タバコ (インヴェストメンツ) リミテッドBritish Americantobacco (Investments) Limited Smoking goods and other flow delivery items
US10525216B2 (en)*2012-02-212020-01-07Respira Therapeutics, Inc.Powder dispersion methods and devices
US11471623B2 (en)2012-02-212022-10-18Respira Therapeutics, Inc.Powder dispersion methods and devices
US10682476B2 (en)2012-02-212020-06-16Respira Therapeutics, Inc.Powder inhaler, system and methods
US20160199598A1 (en)*2012-02-212016-07-14Respira Therapeutics, Inc.Powder dispersion methods and devices
US9649454B2 (en)2012-05-032017-05-16Manta Devices, LlcDelivery device and related methods
US10441733B2 (en)2012-06-252019-10-15Respira Therapeutics, Inc.Powder dispersion devices and methods
EP2928315A2 (en)*2012-12-062015-10-14AeroDesigns, IncAerosol dispenser with edible cartridge
US20150367366A1 (en)*2012-12-062015-12-24Aerodesigns, Inc.Aerosol dispenser with edible cartridge
US10537692B2 (en)2013-04-282020-01-21Impel Neuropharma, Inc.Medical unit dose container
US11191910B2 (en)2013-04-282021-12-07Impel Neuropharma, Inc.Medical unit dose container
US11147936B2 (en)2014-05-022021-10-19Manta Devices, LlcDose delivery device with cover connected to dose chamber seal
CN105311717A (en)*2014-08-012016-02-10心诚镁行动医电股份有限公司Portable ultrasonic atomizer and medicine placing structure thereof
US11266799B2 (en)2015-09-102022-03-08Impel Neuropharma, Inc.In-line nasal delivery device
US11123501B2 (en)2016-03-242021-09-21Nicoventures Holdings LimitedElectronic vapor provision system
US11213638B2 (en)2016-03-242022-01-04Nicoventures Trading LimitedVapor provision system
US11241043B2 (en)2016-03-242022-02-08Nicoventures Trading LimitedVapor provision apparatus
CN109688854A (en)*2016-09-142019-04-26英美烟草(投资)有限公司Receiver section
EP3519025A4 (en)*2016-09-302020-08-26De Motu Cordis Pty Ltd RELEASE DEVICE AND RELATED METHOD OF USE
RU2761750C2 (en)*2017-05-312021-12-13Филип Моррис Продактс С.А.Inhaling product with closing element for air flow
WO2018220475A1 (en)*2017-05-312018-12-06Philip Morris Products S.A.Inhaler article with occluded airflow element
US11452825B2 (en)2017-05-312022-09-27Philip Morris Products S.A.Inhaler article with occluded airflow element
JP2020521474A (en)*2017-05-312020-07-27フィリップ・モーリス・プロダクツ・ソシエテ・アノニム Inhaler article with blocked airflow element
US11571532B2 (en)2017-11-212023-02-07Impel Pharmaceuticals Inc.Intranasal device with dip tube
US11395887B2 (en)2017-11-212022-07-26Impel Pharmaceuticals Inc.Intranasal device with inlet interface
US11878110B2 (en)2017-11-212024-01-23Impel Pharmaceuticals Inc.Intranasal device with inlet interface
US11752100B2 (en)2018-01-052023-09-12Impel Pharmaceuticals Inc.Intranasal delivery of olanzapine by precision olfactory device
US11278492B2 (en)2018-01-052022-03-22Impel Neuropharma, Inc.Intranasal delivery of olanzapine by precision olfactory device
US11185497B2 (en)2018-01-052021-11-30Impel Neuropharma, Inc.Intranasal delivery of dihydroergotamine by precision olfactory device
US11690819B2 (en)2018-07-192023-07-04Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's disease
US11517548B2 (en)2018-07-192022-12-06Impel Pharmaceuticals Inc.Respiratory tract delivery of levodopa and DOPA decarboxylase inhibitor for treatment of Parkinson's Disease
US11759585B2 (en)2019-01-032023-09-19Impel Pharmaceuticals Inc.Nasal drug delivery device with detachable nozzle
CN113490522B (en)*2019-03-052023-10-17菲利普莫里斯生产公司Holder for an inhaler product
CN113490522A (en)*2019-03-052021-10-08菲利普莫里斯生产公司Holder for an inhaler article
WO2020178714A1 (en)*2019-03-052020-09-10Philip Morris Products S.A.Holder for inhaler article
US11878109B2 (en)2019-05-172024-01-23Impel Pharmaceuticals Inc.Single-use nasal delivery device
US20220379053A1 (en)*2019-10-252022-12-01Philip Morris Products S.A.Holder for inhaler article

Similar Documents

PublicationPublication DateTitle
US3888253A (en)Device for administration of medicines
CA2141465C (en)Medicament inhaler and method
US2517482A (en)Inhaler
CN1859938B (en)Unit dose cartridge and dry powder inhaler
US4570630A (en)Medicament inhalation device
US3809084A (en)Pressurized portable dispenser
US6948496B2 (en)Inhalers
US6427688B1 (en)Dry powder inhaler
US5797391A (en)Inhaler
RU2141849C1 (en)Device for spraying of powder-like medicament
AU652242B2 (en)Inhaler
US2722935A (en)Powder dispenser
FI58076C (en) ANORDNING FOER ORAL INHALATION AV FINFOERDELADE FASTA CEILINGS
GB2547279A (en)Inhaler device
EP0506292A1 (en)Inhaler
EP1649886B1 (en)Unit dose capsules for a dry powder inhaler
HK1003427B (en)Powder medicament inhaler

[8]ページ先頭

©2009-2025 Movatter.jp